BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 22560139)

  • 1. Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.
    Cardones AR; Hall RP
    Immunol Allergy Clin North Am; 2012 May; 32(2):263-74, vi. PubMed ID: 22560139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.
    Cardones AR; Hall RP
    Dermatol Clin; 2011 Jul; 29(3):469-77, x. PubMed ID: 21605814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.
    Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T
    Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatitis herpetiformis.
    Otley C; Hall RP
    Dermatol Clin; 1990 Oct; 8(4):759-69. PubMed ID: 2249367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of dermatitis herpetiformis.
    Cardones AR; Hall RP
    Immunol Allergy Clin North Am; 2012 May; 32(2):275-81, vi-vii. PubMed ID: 22560140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatitis herpetiformis.
    Kárpáti S
    Clin Dermatol; 2012; 30(1):56-9. PubMed ID: 22137227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.
    Hall RP; Lawley TJ
    J Immunol; 1985 Sep; 135(3):1760-5. PubMed ID: 4020133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy.
    Hall RP; Owen S; Smith A; Keough M; Bagheri B; Church P; Streilein R
    Exp Dermatol; 2000 Aug; 9(4):275-82. PubMed ID: 10949550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is dermatitis herpetiformis changing?
    Antiga E; Fabbri P; Caproni M
    G Ital Dermatol Venereol; 2013 Apr; 148(2):159-62. PubMed ID: 23588140
    [No Abstract]   [Full Text] [Related]  

  • 10. Gluten-free diet for dermatitis herpetiformis: the long-term effect on cutaneous, immunological and jejunal manifestations.
    Frödin T; Gotthard R; Hed J; Molin L; Norrby K; Walan A
    Acta Derm Venereol; 1981; 61(5):405-11. PubMed ID: 6172928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation.
    Bolotin D; Petronic-Rosic V
    J Am Acad Dermatol; 2011 Jun; 64(6):1017-24; quiz 1025-6. PubMed ID: 21571167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
    Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
    J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.
    Reunala T; Salmi TT; Hervonen K
    Acta Derm Venereol; 2015 Nov; 95(8):917-22. PubMed ID: 26059085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exception within the group of autoimmune blistering diseases: dermatitis herpetiformis, the gluten-sensitive dermopathy.
    Kárpáti S
    Immunol Allergy Clin North Am; 2012 May; 32(2):255-62, vi. PubMed ID: 22560138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatitis Herpetiformis Refractory to Gluten-free Dietary Treatment.
    Hervonen K; Salmi TT; Ilus T; Paasikivi K; Vornanen M; Laurila K; Lindfors K; Viiri K; Saavalainen P; Collin P; Kaukinen K; Reunala T
    Acta Derm Venereol; 2016 Jan; 96(1):82-6. PubMed ID: 26084552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha.
    Hall RP; Takeuchi F; Benbenisty KM; Streilein RD
    J Invest Dermatol; 2006 Jun; 126(6):1331-7. PubMed ID: 16575390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase.
    Dahlbom I; Korponay-Szabó IR; Kovács JB; Szalai Z; Mäki M; Hansson T
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):140-6. PubMed ID: 19841593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatitis herpetiformis. Immunologic concomitants of small intestinal disease and relationship to histocompatibility antigen HL-A8.
    Gebhard RL; Falchuk ZM; Katz SI; Sessoms C; Rogentine GN; Strober W
    J Clin Invest; 1974 Jul; 54(1):98-103. PubMed ID: 4834885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
    Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
    J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatitis Herpetiformis: Novel Perspectives.
    Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
    Front Immunol; 2019; 10():1290. PubMed ID: 31244841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.